Risperidone significantly inhibits interferon-γ-induced microglial activation in vitro

Schizophrenia Research

Volumn 92, Issue 1-3, 2007, Pages 108-115

  Kato, Takahiro ^a   Monji, Akira ^a   Hashioka, Sadayuki ^a   Kanba, Shigenobu ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Antipsychotics; Cytokine; Inflammation; Microglia; Nitric oxide; Schizophrenia

Indexed keywords

GAMMA INTERFERON; HALOPERIDOL; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; RISPERIDONE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DEGENERATIVE DISEASE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; INFLAMMATION; MICROGLIA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; WESTERN BLOTTING;

ANIMALS; ANTIPSYCHOTIC AGENTS; BLOTTING, WESTERN; CELL LINE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HALOPERIDOL; INTERFERON TYPE II; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; MICROGLIA; NITRIC OXIDE; RISPERIDONE; SCHIZOPHRENIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34147102249     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.01.019     Document Type: Article

References (54)

1. Bernstein H.G., Bogerts B., and Keilhoff G. The many faces of nitric oxide in schizophrenia. A review. Schizophr. Res. 78 (2005) 69-86
2. Blin O. A comparative review of new antipsychotics. Can. J. Psychiatry 44 (1999) 235-244
3. Block M.L., and Hong J.S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 76 (2005) 77-98
4. Buckley P.F. New dimensions in the pharmacologic treatment of schizophrenia and related psychoses. J. Clin. Pharmacol. 37 (1997) 363-378
5. Buntinx M., Gielen E., Van Hummelen P., Raus J., Ameloot M., Steels P., and Stinissen P. Cytokine-induced cell death in human oligodendroglial cell lines. II: alterations in gene expression induced by interferon-gamma and tumor necrosis factor-alpha. J. Neurosci. Res. 76 (2004) 846-861
6. Buntinx M., Moreels M., Vandenabeele F., Lambrichts I., Raus J., Steels P., Stinissen P., and Ameloot M. Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis. J. Neurosci. Res. 76 (2004) 834-845
7. Cardenas A., Moro M.A., Hurtado O., Leza J.C., and Lizasoain I. Dual role of nitric oxide in adult neurogenesis. Brain Res. Brain Res. Rev. 50 (2005) 1-6
8. Cazzullo C.L., Sacchetti E., Galluzzo A., Panariello A., Colombo F., Zagliani A., and Clerici M. Cytokine profiles in drug-naive schizophrenic patients. Schizophr. Res. 47 (2001) 293-298
9. Cazzullo C.L., Sacchetti E., Galluzzo A., Panariello A., Adorni A., Pegoraro M., Bosis S., Colombo F., Trabattoni D., Zagliani A., and Clerici M. Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study. Prog. Neuro-psychopharmacol. Biol. Psychiatry 26 (2002) 33-39
10. Chakos M.H., Schobel S.A., Gu H., Gerig G., Bradford D., Charles C., and Lieberman J.A. Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. Br. J. Psychiatry 186 (2005) 26-31
11. Davis K.L., Stewart D.G., Friedman J.I., Buchsbaum M., Harvey P.D., Hof P.R., Buxbaum J., and Haroutunian V. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch. Gen. Psychiatry 60 (2003) 443-456
12. Drzyzga L., Obuchowicz E., Marcinowska A., and Herman Z.S. Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav. Immun. 20 (2006) 532-545
13. Ekdahl C.T., Claasen J.H., Bonde S., Kokaia Z., and Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 13632-13637
14. Farber K., Pannasch U., and Kettenmann H. Dopamine and noradrenaline control distinct functions in rodent microglial cells. Mol. Cell. Neurosci. 29 (2005) 128-138
15. Flynn S.W., Lang D.J., Mackay A.L., Goghari V., Vavasour I.M., Whittall K.P., Smith G.N., Arango V., Mann J.J., Dwork A.J., Falkai P., and Honer W.G. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol. Psychiatry 8 (2003) 811-820
16. Girgis R.R., Diwadkar V.A., Nutche J.J., Sweeney J.A., Keshavan M.S., and Hardan A.Y. Risperidone in first-episode psychosis: a longitudinal, exploratory voxel-based morphometric study. Schizophr. Res. 82 (2006) 89-94
17. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., Haroutunian V., and Fienberg A.A. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4746-4751
18. Halim N.D., Weickert C.S., McClintock B.W., Weinberger D.R., and Lipska B.K. Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus. Neuropsychopharmacology 29 (2004) 1063-1069
19. Hirsch S. Clinical changes measured by [11C](R)-PK11195 PET in patients with psychosis and cognitive decline are associated with impaired event related potential mismatch negativity (abstract from the 12th biennial winter workshop on schizophrenia, Davos, Switzerland). Schizophr. Res. 67 (2004)
20. Hou Y., Wu C.F., Yang J.Y., He X., Bi X.L., Yu L., and Guo T. Effects of clozapine, olanzapine and haloperidol on nitric oxide production by lipopolysaccharide-activated N9 cells. Prog. Neuro-psychopharmacol. Biol. Psychiatry 30 (2006) 1523-1528
21. Kaneko N., Kudo K., Mabuchi T., Takemoto K., Fujimaki K., Wati H., Iguchi H., Tezuka H., and Kanba S. Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus. Neuropsychopharmacology 31 (2006) 2619-2626
22. Kanzawa T., Sawada M., Kato K., Yamamoto K., Mori H., and Tanaka R. Differentiated regulation of allo-antigen presentation by different types of murine microglial cell lines. J. Neurosci. Res. 62 (2000) 383-388
23. Kowalski J., Labuzek K., and Herman Z.S. Flupentixol and trifluperidol reduce secretion of tumor necrosis factor-alpha and nitric oxide by rat microglial cells. Neurochem. Int. 43 (2003) 173-178
24. Kowalski J., Labuzek K., and Herman Z.S. Flupentixol and trifluperidol reduce interleukin-1 beta and interleukin-2 release by rat mixed glial and microglial cell cultures. Pol. J. Pharmacol. 56 (2004) 563-570
25. Kumra S., Ashtari M., Cervellione K.L., Henderson I., Kester H., Roofeh D., Wu J., Clarke T., Thaden E., Kane J.M., Rhinewine J., Lencz T., Diamond A., Ardekani B.A., and Szeszko P.R. White matter abnormalities in early-onset schizophrenia: a voxel-based diffusion tensor imaging study. J. Am. Acad. Child Adolesc. Psych. 44 (2005) 934-941
26. Labuzek K., Kowalski J., Gabryel B., and Herman Z.S. Chlorpromazine and loxapine reduce interleukin-1beta and interleukin-2 release by rat mixed glial and microglial cell cultures. Eur. Neuropsychopharmacol. 15 (2005) 23-30
27. Li J., Baud O., Vartanian T., Volpe J.J., and Rosenberg P.A. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9936-9941
28. Lieberman J.A. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol. Psychiatry 46 (1999) 729-739
29. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Keefe R.S., Davis S.M., Davis C.E., Lebowitz B.D., Severe J., and Hsiao J.K. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 353 (2005) 1209-1223
30. Lieberman J.A., Tollefson G.D., Charles C., Zipursky R., Sharma T., Kahn R.S., Keefe R.S., Green A.I., Gur R.E., McEvoy J., Perkins D., Hamer R.M., Gu H., and Tohen M. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry 62 (2005) 361-370
31. Lin A., Kenis G., Bignotti S., Tura G.J., De Jong R., Bosmans E., Pioli R., Altamura C., Scharpe S., and Maes M. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr. Res. 32 (1998) 9-15
32. Liu J., Suzuki T., Seki T., Namba T., Tanimura A., and Arai H. Effects of repeated phencyclidine administration on adult hippocampal neurogenesis in the rat. Synapse 60 (2006) 56-68
33. Lu L.X., Guo S.Q., Chen W., Li Q., Cheng J., and Guo J.H. Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia. Di Yi Junyi Daxue Xuebao 24 (2004) 1251-1254
34. Massana G., Salgado-Pineda P., Junque C., Perez M., Baeza I., Pons A., Massana J., Navarro V., Blanch J., Morer A., Mercader J.M., and Bernardo M. Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone. J. Clin. Psychopharmacol. 25 (2005) 111-117
35. McGeer P.L., Kawamata T., Walker D.G., Akiyama H., Tooyama I., and McGeer E.G. Microglia in degenerative neurological disease. Glia 7 (1993) 84-92
36. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., and Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151 (1993) 2132-2141
37. Monje M.L., Toda H., and Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 302 (2003) 1760-1765
38. Muller N., Riedel M., Scheppach C., Brandstatter B., Sokullu S., Krampe K., Ulmschneider M., Engel R.R., Moller H.J., and Schwarz M.J. Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am. J. Psychiatry 159 (2002) 1029-1034
39. Reif A., Fritzen S., Finger M., Strobel A., Lauer M., Schmitt A., and Lesch K.P. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol. Psychiatry 11 (2006) 514-522
40. Rothermundt M., Arolt V., and Bayer T.A. Review of immunological and immunopathological findings in schizophrenia. Brain Behav. Immun. 15 (2001) 319-339
41. Sawada M., Imai F., Suzuki H., Hayakawa M., Kanno T., and Nagatsu T. Brain-specific gene expression by immortalized microglial cell-mediated gene transfer in the mammalian brain. FEBS Lett. 433 (1998) 37-40
42. Schwarz M.J., Chiang S., Muller N., and Ackenheil M. T-helper-1 and T-helper-2 responses in psychiatric disorders. Brain Behav. Immun. 15 (2001) 340-370
43. Schwarz M.J., Muller N., Riedel M., and Ackenheil M. The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms. Med. Hypotheses 56 (2001) 483-486
44. Steiner J., Mawrin C., Ziegeler A., Bielau H., Ullrich O., Bernstein H.G., and Bogerts B. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol. (Berl.) 112 (2006) 305-316
45. Stoll G., and Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog. Neurobiol. 58 (1999) 233-247
46. Takeuchi H., Wang J., Kawanokuchi J., Mitsuma N., Mizuno T., and Suzumura A. Interferon-gamma induces microglial-activation-induced cell death: a hypothetical mechanism of relapse and remission in multiple sclerosis. Neurobiol. Dis. 22 (2006) 33-39
47. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., Starkey M., Webster M.J., Yolken R.H., and Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362 (2003) 798-805
48. Uranova N.A., Vostrikov V.M., Orlovskaya D.D., and Rachmanova V.I. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr. Res. 67 (2004) 269-275
49. Vallieres L., Campbell I.L., Gage F.H., and Sawchenko P.E. Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J. Neurosci. 22 (2002) 486-492
50. van Berckel B.B.R., Caspers E., Cahn W., Lammertsma A., and Kahn R. Microglia activation in schizophrenia: an (R)-[11C]-PK11195 positron emission tomography study (abstract from the 2005 international congress on schizophrenia research, Savannah, Georgia). Schizophr. Bull. 31 (2005)
51. Wakade C.G., Mahadik S.P., Waller J.L., and Chiu F.C. Atypical neuroleptics stimulate neurogenesis in adult rat brain. J. Neurosci. Res. 69 (2002) 72-79
52. Wang H.D., Dunnavant F.D., Jarman T., and Deutch A.Y. Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat. Neuropsychopharmacology 29 (2004) 1230-1238
53. Warner-Schmidt J.L., and Duman R.S. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 16 (2006) 239-249
54. Zhang X.Y., Zhou D.F., Cao L.Y., Zhang P.Y., Wu G.Y., and Shen Y.C. Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. J. Clin. Psychiatry 65 (2004) 940-947